Related Experiment Videos
Expression of basic fibroblast growth factor and its receptor in angiosarcoma
T Yamamoto1, T Umeda, H Yokozeki
1Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, Japan.
Journal of the American Academy of Dermatology
|July 20, 1999
Summary
Basic fibroblast growth factor (FGF2) promotes angiosarcoma growth and metastasis. Elevated serum FGF2 levels are linked to nodular angiosarcoma, suggesting its role in tumor progression.
Area of Science:
- Oncology
- Vascular Biology
- Cancer Research
Background:
- Angiosarcoma is a rare, aggressive vascular tumor with high metastatic potential.
- Basic fibroblast growth factor (FGF2) and its receptor are implicated in neoplasia, promoting tumor vascularization and growth.
Purpose of the Study:
- To investigate the immunohistologic localization of FGF2 and its receptor in angiosarcoma.
- To determine the role of FGF2 in angiosarcoma growth and progression.
Main Methods:
- Immunohistochemistry was used to examine FGF2 and its receptor expression in angiosarcoma tissues.
- Serum FGF2 levels were analyzed in patients with different types of angiosarcoma.
Main Results:
- FGF2 is synthesized by tumor endothelial cells in angiosarcoma.
- FGF2 plays a significant role in the growth and progression of angiosarcoma.
- Elevated serum FGF2 levels were observed in patients with nodular angiosarcoma.
Conclusions:
- Tumor-derived FGF2 is crucial for angiosarcoma development and progression.
- Serum FGF2 levels may serve as a biomarker for nodular angiosarcoma.